vs
ENANTA PHARMACEUTICALS INC（ENTA）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
RBB Bancorp的季度营收约是ENANTA PHARMACEUTICALS INC的1.7倍（$32.3M vs $18.6M），RBB Bancorp净利率更高（31.5% vs -64.1%，领先95.6%），RBB Bancorp同比增速更快（12.6% vs 9.8%），RBB Bancorp自由现金流更多（$42.6M vs $-11.8M），过去两年RBB Bancorp的营收复合增速更高（7.0% vs 4.5%）
Enanta制药是一家临床阶段生物技术企业，专注于研发针对乙型肝炎病毒、呼吸道合胞病毒、新冠病毒等传染性疾病的创新抗病毒疗法，与全球制药伙伴合作推进小分子候选药物管线，满足未被覆盖的临床需求。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
ENTA vs RBB — 直观对比
营收规模更大
RBB
是对方的1.7倍
$18.6M
营收增速更快
RBB
高出2.8%
9.8%
净利率更高
RBB
高出95.6%
-64.1%
自由现金流更多
RBB
多$54.4M
$-11.8M
两年增速更快
RBB
近两年复合增速
4.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.6M | $32.3M |
| 净利润 | $-11.9M | $10.2M |
| 毛利率 | — | — |
| 营业利润率 | -60.5% | 39.5% |
| 净利率 | -64.1% | 31.5% |
| 营收同比 | 9.8% | 12.6% |
| 净利润同比 | 46.4% | 132.1% |
| 每股收益（稀释后） | $-0.42 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ENTARBB
| Q4 25 | $18.6M | $32.3M | ||
| Q3 25 | $15.1M | $32.6M | ||
| Q2 25 | $18.3M | $35.8M | ||
| Q1 25 | $14.9M | $28.5M | ||
| Q4 24 | $17.0M | $28.7M | ||
| Q3 24 | $14.6M | $30.3M | ||
| Q2 24 | $18.0M | $27.5M | ||
| Q1 24 | $17.1M | $28.2M |
净利润ENTARBB
| Q4 25 | $-11.9M | $10.2M | ||
| Q3 25 | $-18.7M | $10.1M | ||
| Q2 25 | $-18.3M | $9.3M | ||
| Q1 25 | $-22.6M | $2.3M | ||
| Q4 24 | $-22.3M | $4.4M | ||
| Q3 24 | $-28.8M | $7.0M | ||
| Q2 24 | $-22.7M | $7.2M | ||
| Q1 24 | $-31.2M | $8.0M |
营业利润率ENTARBB
| Q4 25 | -60.5% | 39.5% | ||
| Q3 25 | -121.6% | 40.7% | ||
| Q2 25 | -103.2% | 36.1% | ||
| Q1 25 | -164.3% | 11.2% | ||
| Q4 24 | -138.8% | 17.6% | ||
| Q3 24 | -204.4% | 31.6% | ||
| Q2 24 | -134.6% | 35.6% | ||
| Q1 24 | -192.1% | 39.9% |
净利率ENTARBB
| Q4 25 | -64.1% | 31.5% | ||
| Q3 25 | -123.6% | 31.2% | ||
| Q2 25 | -99.7% | 26.1% | ||
| Q1 25 | -151.7% | 8.0% | ||
| Q4 24 | -131.4% | 15.3% | ||
| Q3 24 | -197.3% | 23.1% | ||
| Q2 24 | -126.1% | 26.4% | ||
| Q1 24 | -182.7% | 28.4% |
每股收益（稀释后）ENTARBB
| Q4 25 | $-0.42 | $0.59 | ||
| Q3 25 | $-0.88 | $0.59 | ||
| Q2 25 | $-0.85 | $0.52 | ||
| Q1 25 | $-1.06 | $0.13 | ||
| Q4 24 | $-1.05 | $0.26 | ||
| Q3 24 | $-1.36 | $0.39 | ||
| Q2 24 | $-1.07 | $0.39 | ||
| Q1 24 | $-1.47 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.4M | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $126.6M | $523.4M |
| 总资产 | $329.5M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资ENTARBB
| Q4 25 | $37.4M | $212.3M | ||
| Q3 25 | $32.3M | $234.9M | ||
| Q2 25 | $44.8M | $191.9M | ||
| Q1 25 | $60.2M | $238.8M | ||
| Q4 24 | $84.3M | $257.7M | ||
| Q3 24 | $37.2M | $349.4M | ||
| Q2 24 | $35.8M | $252.8M | ||
| Q1 24 | $63.5M | — |
总债务ENTARBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | — | $119.8M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | — | $119.6M | ||
| Q4 24 | — | $119.5M | ||
| Q3 24 | — | $119.4M | ||
| Q2 24 | — | $119.3M | ||
| Q1 24 | — | $119.2M |
股东权益ENTARBB
| Q4 25 | $126.6M | $523.4M | ||
| Q3 25 | $64.7M | $514.3M | ||
| Q2 25 | $79.3M | $517.7M | ||
| Q1 25 | $93.5M | $510.3M | ||
| Q4 24 | $111.8M | $507.9M | ||
| Q3 24 | $128.8M | $509.7M | ||
| Q2 24 | $148.9M | $511.3M | ||
| Q1 24 | $166.1M | $514.0M |
总资产ENTARBB
| Q4 25 | $329.5M | $4.2B | ||
| Q3 25 | $280.7M | $4.2B | ||
| Q2 25 | $301.0M | $4.1B | ||
| Q1 25 | $323.0M | $4.0B | ||
| Q4 24 | $348.6M | $4.0B | ||
| Q3 24 | $376.7M | $4.0B | ||
| Q2 24 | $398.8M | $3.9B | ||
| Q1 24 | $413.6M | $3.9B |
负债/权益比ENTARBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-11.7M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $-11.8M | $42.6M |
| 自由现金流率自由现金流/营收 | -63.6% | 131.8% |
| 资本支出强度资本支出/营收 | 0.8% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | $-18.5M | $73.5M |
8季度趋势，按日历期对齐
经营现金流ENTARBB
| Q4 25 | $-11.7M | $43.4M | ||
| Q3 25 | $-6.5M | $2.1M | ||
| Q2 25 | $17.5M | $21.7M | ||
| Q1 25 | $-13.5M | $7.8M | ||
| Q4 24 | $-16.8M | $58.5M | ||
| Q3 24 | $-10.4M | $24.5M | ||
| Q2 24 | $-14.8M | $11.7M | ||
| Q1 24 | $-28.6M | $4.8M |
自由现金流ENTARBB
| Q4 25 | $-11.8M | $42.6M | ||
| Q3 25 | $-7.9M | $1.8M | ||
| Q2 25 | $17.4M | $21.6M | ||
| Q1 25 | $-16.0M | $7.6M | ||
| Q4 24 | $-25.5M | $57.7M | ||
| Q3 24 | $-19.4M | $24.2M | ||
| Q2 24 | $-21.3M | $11.5M | ||
| Q1 24 | $-30.3M | $4.7M |
自由现金流率ENTARBB
| Q4 25 | -63.6% | 131.8% | ||
| Q3 25 | -52.5% | 5.4% | ||
| Q2 25 | 94.7% | 60.2% | ||
| Q1 25 | -107.4% | 26.7% | ||
| Q4 24 | -150.6% | 201.0% | ||
| Q3 24 | -132.5% | 80.0% | ||
| Q2 24 | -118.6% | 42.0% | ||
| Q1 24 | -177.5% | 16.6% |
资本支出强度ENTARBB
| Q4 25 | 0.8% | 2.5% | ||
| Q3 25 | 9.6% | 1.1% | ||
| Q2 25 | 0.8% | 0.3% | ||
| Q1 25 | 17.0% | 0.6% | ||
| Q4 24 | 51.6% | 2.7% | ||
| Q3 24 | 61.3% | 0.8% | ||
| Q2 24 | 36.4% | 0.5% | ||
| Q1 24 | 9.8% | 0.5% |
现金转化率ENTARBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
